HPV Vaccine: Continuous Protection Beyond Six Years
December 5, 2009 by admin
An article published Online First and in an upcoming edition of The Lancet reports that the ‘Cervarix’ human papilloma virus (HPV) vaccine from GlaxoSmithKline offers continued protection beyond six years from infection against the types of HPV most commonly associated with cervical cancer (HPV-16 and HPV-18)…
Comments